Brief: BioArctic Says CHMP Issues Positive Recommendation For Approval Of Lecanemab In The EU
14/11/2024 16:08
Nov 14 (Reuters) - BioArctic AB BIOAb.ST :
* CHMP ISSUES POSITIVE RECOMMENDATION FOR APPROVAL OF
LECANEMAB IN
THE EU
Source text: ID:nWkrcc0czS
Further company coverage: BIOAb.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioArctic AB
See all newsBrief: BioArctic And Lilly Sign Research, Collaboration Agreement
Brief: Bioarctic AB Declares Dividend Of Sek 2 Per Share With 1 June 2026 Record Date
Brief: Bioarctic Partner Eisai Presents Leqembi Sales Simulation
Sweden's BioArctic Q1 revenue drops sharply despite higher Leqembi royalties
Brief: BioArctic Q1 Operating Profit SEK 210.8 Million